dimethyl fumarate teva
teva gmbh - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressive - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
sunitinib teva 12.5 mg
teva b.v. - sunitinib - kapsel, hard - 12.5 mg
sunitinib teva 25 mg
teva b.v. - sunitinib - kapsel, hard - 25 mg
sunitinib teva 50 mg
teva b.v. - sunitinib - kapsel, hard - 50 mg
balidax 30 mg
teva b.v. - lisdeksamfetamindimesilat - kapsel, hard - 30 mg
balidax 20 mg
teva b.v. - lisdeksamfetamindimesilat - kapsel, hard - 20 mg
balidax 40 mg
teva b.v. - lisdeksamfetamindimesilat - kapsel, hard - 40 mg
balidax 50 mg
teva b.v. - lisdeksamfetamindimesilat - kapsel, hard - 50 mg
balidax 60 mg
teva b.v. - lisdeksamfetamindimesilat - kapsel, hard - 60 mg
balidax 70 mg
teva b.v. - lisdeksamfetamindimesilat - kapsel, hard - 70 mg